Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Janux Therapeutics develops intratumoral immuno-oncology therapies as nasdaq 100 index discussions highlight biotech ...

Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Treatment with the tumour necrosis factor receptor 2 (TNFR2)-targeting monoclonal antibody (mAb) plus Keytruda was also found ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...

Introduction: A patient-derived head and neck cancer organoid (HNCO) model that can reconstruct the tumor-immune microenvironment (TME) was established using air-liquid interface (ALI) culture ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Lung adenocarcinoma (LUAD) remains one of the world’s most fatal cancers, driven by complex genetic and epigenetic ...

Chronic circadian disruption — such as night-shift work, irregular schedules, or frequent jet lag — accelerates the ...